NME: Topical nonsteroid for second-line eczema Tx
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Research Shows Hidradenitis Suppurativa Impacts 1% Globally, With Women More Affected
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
New Data at EADV Could Offer Hope, Address Gaps in Dermatology Care
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s